Antimicrobial resistance survivors: calling the world to action
- PMID: 38797181
- DOI: 10.1016/S0140-6736(24)01030-4
Antimicrobial resistance survivors: calling the world to action
Conflict of interest statement
NS received funding from Pfizer to attend and present at ECCMID 2023. RP has received funding to attend PACCARB 2024, TIMM 2023, and ECCMID 2024; and received consulting fees from Clinical Outcome Solutions. VC has received payment to present her story from Pfizer, bioMerieux, A Menarini, Cepheid, International Dental Federation, British Society of Antimicrobial Chemotherapy (BSAC), and NHS Wales; has received support from Roche, Warwick University, Imperial College London, Fleming Initiative, WHO, and BSAC, and the CDC foundation to attend meetings; and is the Executive Director of The AMR Narrative, a UK registered charity. All other authors declare no competing interests.
Comment on
-
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.Lancet. 2024 Jun 8;403(10443):2534-2550. doi: 10.1016/S0140-6736(24)00878-X. Epub 2024 May 23. Lancet. 2024. PMID: 38797178 Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
